Clinical assessment of antisecretory drugs in man.
1982; Wiley; Volume: 14; Issue: 1 Linguagem: Inglês
10.1111/j.1365-2125.1982.tb04929.x
ISSN1365-2125
Autores Tópico(s)Helicobacter pylori-related gastroenterology studies
ResumoBritish Journal of Clinical PharmacologyVolume 14, Issue 1 p. 15-23 Free Access Clinical assessment of antisecretory drugs in man. EJ Boyd, EJ BoydSearch for more papers by this authorKG Wormsley, KG WormsleySearch for more papers by this author EJ Boyd, EJ BoydSearch for more papers by this authorKG Wormsley, KG WormsleySearch for more papers by this author First published: July 1982 https://doi.org/10.1111/j.1365-2125.1982.tb04929.xCitations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References AADLAND, E. & BERSTAD, A. (1979). Effect of cimetidine on histamine- and pentagastrin-stimulated gastric secretion in healthy subjects. Scand. J. Gastroenterol., 14, 367– 372. ADAM, H.M., CARD, W.I., RIDDELL, M.J., ROBERTS, M., STRONG, J.A. & WOOLF, B. (1954). Dose response curves for the effect of histamine on gastric acid secretion in man. Br. J. Pharmac., 9, 329– 334. BAJAJ, S.C. & HIRSCHOWITZ, B.I. (1976). Inhibition of basal and stimulated gastric H+ and pepsin secretion in duodenal ulcer patients by metiamide an H-2 histamine antagonist. Digest. Dis., 21, 557– 562. BARBEZAT, G.O. & BANK, S. (1976). Effect of a histamine H2-receptor antagonist and an anticholinergic on gastric acid secretion in man. S. Afr. med. J., 50, 849– 851. BARON, J.H. (1978). Clinical tests of gastric secretion. History, methodology and interpretation. London: Macmillan Press Ltd. BERSTAD, A., FRISLID, K. & RYDNING, A. (1982). Relationship between ranitidine plasma levels and reduction of postprandial intragastric acidity in healthy man. Scand. J. Gastroenterol., 17, 109– 112. BODEMAR, G., NORLANDER, B. & WALAN, A. (1981). Pharmacokinetics of cimetidine after single doses and during continuous treatment. Clin. Pharmacokin., 6, 306– 315. BODEMAR, G. & WALAN, A. (1978). Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet, i, 404– 407. BOYD, E.J.S., PEDEN, N.R. & WORMSLEY, K.G. (1981a). Smoking, sex and the treatment of duodenal ulcer. Hepato-Gastroenterol., 28, 63. BOYD, E.J.S., WILSON, J.A. & WORMSLEY, K.G. (1981b). Failure of maintenance therapy in duodenal ulcer. Gut, 22, A880. BURLAND, W.L., DUNCAN, W.A.N., HESSELBO, T., MILLS, J.G., SHARPE, P.L., HAGGIE, S.J. & WYLLIE, J.H. (1975). Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man. Br. J. clin. Pharmac., 2, 481– 486. DAMMAN, H.G. & SIMON, B. (1981). The new histamine H2-receptor antagonist ranitidine — duration of action. Scand. J. Gastroenterol., 16, Suppl. 69, 39– 41. DANILEWITZ, M., TIM, L.O. & HIRSCHOWITZ, B. (1982). Ranitidine suppression of gastric hypersecretion resistant to cimetidine. New Engl. J. Med., 306, 20– 22. DAVENPORT, H.W. (1976). Physiological parameters of the gastric mucosal barrier. Digest. Dis., 21, 141– 143. DAVIES, H.A., RHODES, J. & THOMAS, M. (1981). Inhibition of gastric acid secretion with a mast-cell stabiliser. Br. J. clin. Pharmac., 11, 53– 56. DOWD, J.E. & RIGGS, D.S. (1965). A comparison of estimates of Michaelis-Menten kinetic constants from various linear transformations. J. biol. Chem., 240, 863– 869. FABER, R.G. & HOBSLEY, M. (1977). Basal gastric secretion: Reproducibility and relationship with duodenal ulceration. Gut, 18, 57– 63. HASSAN, M. & HOBSLEY, M. (1970). Positioning of subject and of nasogastric tube during a gastric secretion study. Br. med. J., 1, 458– 460. JOHNSTON, D. & ROBINSON, D.W. (1967). The maximal histalog test of gastric secretion. A comparison with the histamine infusion test in man. Br. J. Surg., 54, 207– 210. LAWRIE, J.H., SMITH, G.M.R. & FORREST, A.P.M. (1964). The histamine infusion test. Lancet, ii, 270– 273. LONGSTRETH, G.F., GO, V.L.W. & MALAGELADA, J.-R. (1977). Postprandial gastric, pancreatic, and biliary response to histamine H2-receptor antagonists in active duodenal ulcer. Gastroenterology, 72, 9– 13. McGUIGAN, J.E. (1978). Sulpiride: An inhibitor of gastrin release. Gastroenterology, 74, 324– 326. MALAGELADA, J.-R., LONGSTRETH, G.F., SUMMER-SKILL, W.H.J. & GO, V.L.W. (1976). Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology, 70, 203– 210. MOBERG, S., CARLBERGER, G., GILLJAM, H. & BEFRITZ, R. (1977). The effect of cimetidine on meal-stimulated gastric functions measured with a new method. Scand. J. Gastroenterol., 12, 145– 148. MODELL, W. & HOUDE, R.W. (1958). Factors influencing the clinical evaluation of drugs, with special reference to the double-blind technique. J. Am. med. Ass., 167, 2190– 2199. MYREN, J., SCHRUMPF, E., BOHMAN, T., SKAUG, O.E. & LARSEN, S. (1979). Serum concentrations of trimipramine (Surmontil) and gastric secretion of acid and pepsin following peroral administration of the drug in healthy volunteers. Scand. J. Gastroenterol., 14, 237– 240. O'BRIEN, P.E. & CARTER, D.C. (1975). Effect of gastric secretory inhibitors on the gastric mucosal barrier. Gut, 16, 437– 442. OBRINK, K.J. (1980). Theoretical considerations concerning gastric inhibition. Scand. J. Gastroenterol., 15, Suppl. 66, 7– 13. OLBE, L., HAGLUND, U., LETH, R., LIND, T., CEDERBERG, C., EKENVED, G., ELANDER, B., FELLENIUS, E. & LUNDBORG, P. (1982). Effects of a substituted benimidazole (H 149/94) on gastric acid secretion in man. Gastroenterology, (in press). POUNDER, R.E., WILLIAMS, J.G., MILTON-THOMSON, G.J. & MISIEWICZ, J.J. (1976). Effect of cimetidine on 24-h intragastric acidity in normal subjects. Gut, 17, 133– 138. RAMSEY, E.J., CAREY, K.V., PETERSON, W.L., JACKSON, J.J., MURPHY, F.K., READ, N.W., TAYLOR, K.B., TRIER, J.S. & FORDTRAN, J.S. (1979). Epidemic gastritis with hypochlorhydria. Gastroenterology, 76, 1449– 1457. REGAN, P.T., MALAGELADA, J.-R., DiMAGNO, E.P. & GO, V.L.W. (1978). Rationale for the use of cimetidine in pancreatic insufficiency. Mayo Clin. Proc., 53, 7943. RICHARDSON, C.T., WALSH, J.H. & HICKS, M.I. (1976). The effect of cimetidine, a new histamine H2-receptor antagonist, on meal-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcer. Gastroenterology, 71, 19– 23. SAUNDERS, J.H.B., THJODLEIFSSON, B. & WORMSLEY, K.G. (1975). Aspects of basal gastric secretion in man. Digestion, 12, 183– 188. SOMOGYI, A., ROHMER, H.G. & GUGLER, R. (1980). Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients. Clin. Pharmacokin., 5, 84– 94. SPENCE, R.W., CREAK, D.R. & CELESTIN, C.R. (1976). Influence of a meal on the absorption of cimetidine—a new histamine H2-receptor antagonist. Digestion, 14, 127– 132. SPENNEY, J.G. (1979). Physical, chemical and technical limitations to intragastric titration. Gastroenterology, 76, 1025– 1034. STENQUIST, B., KNUTSON, U. & OLBE, L. (1978). Gastric acid responses to adequate and modified sham feeding and to insulin hypoglycemia in duodenal ulcer patients. Scand. J. Gastroenterol., 13, 357– 362. THJODLEIFSSON, B. & WORMSLEY, K.G. (1974). Gastric response to metiamide. Br. med. J., 1, 304– 306. THJODLEIFSSON, B. & WORMSLEY, K.G. (1975a). Aspects of the effect of metiamide on pentagastrin-stimulated and basal gastric secretion of acid and pepsin in man. Gut, 16, 501– 508. THJODLEIFSSON, B. & WORMSLEY, K.G. (1975b). Effects of long-term treatment with metiamide. Digestion, 12, 134– 143. THJODLEIFSSON, B. & WORMSLEY, K.G. (1975c). Effects of metiamide on the human stomach. Clin. Sci. mol. Med., 49, 445– 458. VENABLES, C.W. (1972). An assessment of the value of measuring uncollected gastric secretion during routine secretion studies in man. Br. J. Surg., 59, 473– 477. WALT, R.P., MALE, P.J., HUNT, R.H., RAWLINGS, J., MILTON-THOMPSON, G.J. & MISIEWICZ, J.J. (1981). The effect of ranitidine and cimetidine on the twenty-four intragastric acidity profile and nocturnal acid secretion in duodenal ulcer patients. Scand. J. Gastroenterol., 16, Suppl. 69, 33– 36. WHITE, W.D. & JUNIPER, K. (1973). Repeatability of gastric analysis. Am. J. digest. Dis., 18, 7– 13. WORMSLEY, K.G. (1970). Inhibition of gastrointestinal secretion. Gut, 11, 883– 887. WORMSLEY, K.G. (1971). Reactions to acid in the intestine in health and disease. Gut, 12, 674– 4. WORMSLEY, K.G. (1972). Response to pentagastrin in man. I. Rate of secretion of gastric juice. Acta Hepato-Gastroent., 19, 120– 124. Citing Literature Volume14, Issue1July 1982Pages 15-23 ReferencesRelatedInformation
Referência(s)